The Trump administration’s implementation of new tariffs has triggered panic in the financial markets. This sharp decline in stock prices can be a profitable way to invest in the stock market at a bargain price if you are a risk-averse investor with a long-term investment horizon. In this context, it seems wise to ask whether unfairly neglected listed stocks have not reached a particularly attractive valuation, making them a good place to do business on the stock market.
In this article, we have selected two American stocks that have been unfairly beaten down on the stock market and which, in our opinion, have significant rebound potential in the medium to long term. Discover our detailed analysis of these two US stocks, which you may wish to add to your stock portfolio. To acquire these stocks, select the best stockbroker and open the best securities account. Remember that it is not possible to invest in a PEA on stocks whose head office is located outside the European Union.
Amazon Stock Strategic Refocusing for a New Era of Growth
Amazon is an iconic American online retail company known for revolutionizing the global distribution of goods and services. Beyond its marketplace, Amazon is also a major player in cloud computing, with its AWS division generating a significant portion of its profits. For a stock market investor, Amazon shares combine a diversified business model, strong innovation capacity, and a dominant position in several strategic markets.
Fundamental Analysis of Amazon Stock
Looking at the star chart below, Amazon shares display a generally solid fundamental profile, driven by several major strengths, including sustained growth, robust profitability, and now, the payment of Amazon dividends, which marks a strategic turning point for the group.
Let’s start with growth, which remains the core of the Amazon model. Thanks to the diversification of its activities, which include online commerce, cloud computing with AWS, digital advertising, and generative AI, the Amazon group continues to expand its global footprint. This sustained momentum makes Amazon one of the undisputed leaders in American tech, with growth drivers in promising sectors.
On the profitability side, Amazon’s indicators are also very encouraging. EBITDA, at 15.42, is more than half the industry average (36.53), reflecting good operational efficiency in a complex environment. Amazon thus demonstrates its ability to generate solid margins while maintaining an ambitious investment policy.
The other notable new feature is the payment of Amazon dividends. Long absent from Amazon’s strategy, this change strengthens the appeal of Amazon shares to long-term investors seeking yield while highlighting the group’s growing financial maturity.
However, some areas call for caution. The first concerns Amazon’s valuation. With a P/E ratio of 30.98, slightly above the sector average (23.17), Amazon is paying a high price. While it remains below excessive levels, we are approaching a zone where any disappointing results could lead to rapid corrections. The price-to-book ratio, meanwhile, is more reassuring at 6.42 compared to 11.26 in the sector, a reasonable level for a company of this size and quality.
Finally, Amazon’s management, while competent, faces challenges in governance and strategic direction. Jeff Bezos’s succession, growing regulatory pressures, and capital allocation choices in AI and logistics infrastructure will all be factors to watch in the coming years.
In summary, Amazon remains an attractive tech giant, driven by impressive growth, controlled profitability, and solid long-term prospects. Let’s see if we can confirm our fundamental view with a chart analysis of Amazon’s stock price.
Technical analysis of Amazon stock
Since the beginning of February 2025, Amazon’s stock has been in a sharp downward trend, marking a clear break from wfromthe previous momentum. This correction accelerated after Donald Trump announced new tariffs, which severely shook major technology stocks led by Amazon. However, Amazon’s stock appears to have found an anchor at a key technical support level at $161, which has stopped the bleeding for now. Since this low, Amazon’s stock has rebounded and is now heading towards a major resistance level at $185, a pivotal level that will have to be crossed to validate a real reversal.
In the event of a clear break above $185, a first upside target for Amazon shares could be seen at $205, with a second level around $218 if the momentum continues. In the longer term, and although it may seem ambitious today, a return of Amazon shares to the all-time highs of $240 would not be out of the question if the uptrend continues.
Chart analysis of Amazon stock
However, the bullish scenario remains fragile. If the market fails to regain control and the $160 support level were to give way, the momentum could reverse dramatically. In this case, the decline in Amazon’s stock could intensify, with successive targets at $125, then $100, before reaching long-term support around $80. This level would constitute a potential landing point but also a clear signal of a deeper cycle change in Amazon’s stock.
Should You Invest in Amazon Stocks? Our Opinion
Stocks like Amazon, which are among the largest capitalizations in the world, if not the largest depending on the period, rarely offer the opportunity to be bought at price levels that could be described as “sold out.” And yet, this is precisely what seems to be happening now. Of course, the decline may continue, especially in a tense market context. But one thing is certain: starting a DCA strategy on Amazon stock around $173 is significantly more interesting (and potentially more profitable in the long term) than having initiated it at $240, when Amazon stock was trading at its peaks. For patient investors, this pullback phase could, therefore, represent a wise entry point within the framework of an investment plan, for example.
Pfizer, a pharmaceutical giant, is undervalued on the stock market
Pfizer is one of the most well-known American pharmaceutical companies in the world. The company develops and markets innovative drugs, vaccines, and treatments across a wide range of therapeutic areas. It has recently made a name for itself with. For investors, Pfizer represents a key player in the healthcare sector, combining a robust product portfolio, significant research capacity, and a strategic positioning in biotechnology.
Fundamental analysis of Pfizer stock
The star chart below paints a clear picture of the fundamentals of Pfizer, one of the biggest names in the global pharmaceutical industry. And several signs are cositive.
First, Pfizer’s profitability stands out as one of the company’s main strengths. With an EBITDA of 10.53, half the industry average (22.86), Pfizer boasts excellent operational efficiency, the result of a mature product portfolio and recognized expertise in developing and commercializing drugs on a large scale.
Another point of satisfaction: the quality of management. The Pfizer group is led by an experienced team, capable of navigating a complex regulatory environment while ensuring the profitability and stability of the business. Strategic choices, such as investments in biotechnology and targeted acquisitions, demonstrate a clear long-term vision.
Pfizer also stands out for its dividend policy. The company pays a regular and generous Pfizer dividend, which will appeal to investors looking for recurring income. This Pfizer dividend is well-covered by profits, which reinforces its reliability.
